PureQQ (Pyrroloquinoline quinone)

PureQQ is a branded form of pyrroloquinoline quinone (PQQ), a redox-active cofactor compound originally identified in bacterial enzyme systems. Its proposed mechanism involves modulation of mitochondrial biogenesis pathways, though robust human clinical evidence currently remains limited.

Origin & History

PureQQ is a branded form of pyrroloquinoline quinone (PQQ), a redox cofactor naturally biosynthesized in certain bacteria like Klebsiella from glutamate and tyrosine. Commercial PureQQ is typically produced via a 3-step chemical synthesis process rather than extracted from natural sources.

Historical & Cultural Context

PQQ has no documented traditional or historical use in any medicine system. It was first discovered in 1964 as a bacterial redox cofactor in methylotrophic bacteria, with no prior traditional context.

Health Benefits

• No human health benefits documented - search results contain only prokaryotic enzyme mechanism studies
• No clinical trials available to support mitochondrial function claims
• No evidence for cognitive or energy benefits in humans
• No data on antioxidant effects in human subjects
• Current research limited to bacterial biochemistry and biosynthesis pathways

How It Works

Pyrroloquinoline quinone acts as a redox cofactor capable of cycling between oxidized (PQQ) and reduced (PQQH2) forms, theoretically donating electrons within cellular energy metabolism. In prokaryotic systems, PQQ serves as a cofactor for membrane-bound dehydrogenases such as glucose dehydrogenase and methanol dehydrogenase, facilitating electron transfer to the respiratory chain. Whether these mechanisms translate meaningfully to mammalian mitochondrial function — particularly via activation of PGC-1α-mediated mitochondrial biogenesis — has not been confirmed in controlled human trials.

Scientific Research

The search results provide no human clinical trials, RCTs, or meta-analyses for PQQ/PureQQ. Available research focuses exclusively on prokaryotic enzyme mechanisms and biosynthesis pathways in bacteria, with no PubMed PMIDs for human studies provided.

Clinical Summary

No published human clinical trials specifically evaluating the PureQQ branded ingredient were identified at the time of this writing. General PQQ research in humans is sparse; a small number of pilot studies (n=10–20 participants) have explored PQQ disodium salt at doses of 20 mg/day with inconclusive findings on cognitive and energy endpoints. No peer-reviewed randomized controlled trials with adequate statistical power establish efficacy for mitochondrial function, cognitive performance, or antioxidant outcomes in humans. Current evidence is insufficient to support health claims, and most mechanistic data derive from prokaryotic enzyme studies or rodent models.

Nutritional Profile

Pyrroloquinoline quinone (PQQ) is a redox-active quinone cofactor with the molecular formula C14H6N2O8 and molecular weight of 330.21 g/mol. It is not a macronutrient and contributes negligible caloric value. PQQ is found in trace amounts in various foods: fermented soybeans (natto) contain approximately 61 ng/g (highest known dietary source), green tea approximately 28-30 ng/g, green pepper approximately 28 ng/g, kiwi fruit approximately 27 ng/g, tofu approximately 24 ng/g, and human breast milk approximately 140-180 ng/mL. It is neither a vitamin, mineral, nor fiber. PQQ functions biochemically as a cofactor for bacterial dehydrogenase enzymes (methanol dehydrogenase, glucose dehydrogenase) in prokaryotic systems. Estimated typical dietary intake from food sources ranges from approximately 0.1-1.0 mcg/day in standard diets. Commercially available supplements are typically dosed at 10-20 mg (as disodium salt form, BioPQQ), representing doses many orders of magnitude above dietary exposure. Oral bioavailability data in humans is limited; animal studies suggest rapid absorption and urinary excretion. No established Recommended Daily Intake (RDI) or Dietary Reference Intake (DRI) exists. PQQ contains no fiber, protein, or conventional micronutrients.

Preparation & Dosage

No clinically studied dosage ranges are available in the research, as human trials have not been documented. The disodium salt form has a water solubility of 3 g/L at 25°C. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

CoQ10, NAD+ precursors, Alpha-lipoic acid, Resveratrol, Acetyl-L-carnitine

Safety & Interactions

PQQ compounds have shown a generally tolerable profile in the limited short-term human pilot data available, with no severe adverse events reported at doses up to 20 mg/day. Potential interactions with chemotherapeutic agents or anticoagulants have not been formally studied and cannot be ruled out given PQQ's redox activity. Safety during pregnancy and lactation has not been established, and use is not recommended in these populations without medical supervision. Individuals taking medications metabolized via mitochondrial pathways or those with known redox-sensitive conditions should consult a healthcare provider before use.